_id
690f3522ccc777a4e85d16c3
Ticker
BIAF
Name
bioAffinity Technologies, Inc.
Exchange
NASDAQ
Address
3300 Nacogdoches Road, San Antonio, TX, United States, 78217
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.bioaffinitytech.com
Description
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Last Close
1.37
Volume
14835
Current Price
1.3573
Change
-0.0127
Last Updated
2026-01-20T16:32:41.421Z
Image
data:image/webp;base64,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
Ipo Date
2022-09-01T00:00:00.000Z
Market Cap
6163231
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3
Target Price
6
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
1446066
Cost Of Revenue
1055571
Gross Profit
390495
Operating Expenses
2683341
Operating Income
-2292846
Interest Expense
5358
Pretax Income
-5047902
Net Income
-5051084
Eps
-4.73679748675388
Dividends Per Share
-
Shares Outstanding
4498709
Income Tax Expense
3182
EBITDA
-4929184
Operating Margin
-158.55749322645025
Total Other Income Expense Net
-2755056
Cash
7669195
Short Term Investments
-
Receivables
448990
Inventories
35234
Total Current Assets
8613606
Property Plant Equipment
784073
Total Assets
11546369
Payables
940761
Short Term Debt
396350
Long Term Debt
43658
Total Liabilities
2644171
Equity
8902198
Bs_currency_symbol
USD
Depreciation
113360
Change In Working Capital
-357166
Cash From Operations
-2480298
Capital Expenditures
3648
Cash From Investing
3646
Cash From Financing
9343012
Net Change In Cash
6866360
Cf_currency_symbol
USD
PE
-
PB
0.162584212910115
ROE
-56.73974000578285
ROA
-43.74608156035893
FCF
-2483946
Fcf Percent
-1.71772657679525
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
6.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
3.5
Growth Investing Score
2
Momentum Investing Score
3
Net Net Investing Score
3.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1446066
Quarters > 0 > income Statement > cost Of Revenue
1055571
Quarters > 0 > income Statement > gross Profit
390495
Quarters > 0 > income Statement > operating Expenses
2683341
Quarters > 0 > income Statement > operating Income
-2292846
Quarters > 0 > income Statement > interest Expense
5358
Quarters > 0 > income Statement > pretax Income
-5047902
Quarters > 0 > income Statement > net Income
-5051084
Quarters > 0 > income Statement > eps
-4.73679748675388
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1066350
Quarters > 0 > income Statement > income Tax Expense
3182
Quarters > 0 > income Statement > EBITDA
-4929184
Quarters > 0 > income Statement > operating Margin
-158.55749322645025
Quarters > 0 > income Statement > total Other Income Expense Net
-2755056
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
7669195
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
448990
Quarters > 0 > balance Sheet > inventories
35234
Quarters > 0 > balance Sheet > total Current Assets
8613606
Quarters > 0 > balance Sheet > property Plant Equipment
784073
Quarters > 0 > balance Sheet > total Assets
11546369
Quarters > 0 > balance Sheet > payables
940761
Quarters > 0 > balance Sheet > short Term Debt
396350
Quarters > 0 > balance Sheet > long Term Debt
43658
Quarters > 0 > balance Sheet > total Liabilities
2644171
Quarters > 0 > balance Sheet > equity
8902198
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-5051084
Quarters > 0 > cash Flow > depreciation
113360
Quarters > 0 > cash Flow > change In Working Capital
-357166
Quarters > 0 > cash Flow > cash From Operations
-2480298
Quarters > 0 > cash Flow > capital Expenditures
3648
Quarters > 0 > cash Flow > cash From Investing
3646
Quarters > 0 > cash Flow > cash From Financing
9343012
Quarters > 0 > cash Flow > net Change In Cash
6866360
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-4.73679748675388
Quarters > 0 > ratios > PB
0.162584212910115
Quarters > 0 > ratios > ROE
-56.73974000578285
Quarters > 0 > ratios > ROA
-43.74608156035893
Quarters > 0 > ratios > FCF
-2483946
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.71772657679525
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1269483
Quarters > 1 > income Statement > cost Of Revenue
1016602
Quarters > 1 > income Statement > gross Profit
252881
Quarters > 1 > income Statement > operating Expenses
2768441
Quarters > 1 > income Statement > operating Income
-2515560
Quarters > 1 > income Statement > interest Expense
10460
Quarters > 1 > income Statement > pretax Income
-4031803
Quarters > 1 > income Statement > net Income
-4060787
Quarters > 1 > income Statement > eps
-5.07143213965466
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
800718
Quarters > 1 > income Statement > income Tax Expense
28984
Quarters > 1 > income Statement > EBITDA
-3908114
Quarters > 1 > income Statement > operating Margin
-198.15625731104709
Quarters > 1 > income Statement > total Other Income Expense Net
-1516243
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
802835
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
421869
Quarters > 1 > balance Sheet > inventories
43971
Quarters > 1 > balance Sheet > total Current Assets
1668826
Quarters > 1 > balance Sheet > property Plant Equipment
918977
Quarters > 1 > balance Sheet > total Assets
4751075
Quarters > 1 > balance Sheet > payables
1169837
Quarters > 1 > balance Sheet > short Term Debt
346029
Quarters > 1 > balance Sheet > long Term Debt
45952
Quarters > 1 > balance Sheet > total Liabilities
6887183
Quarters > 1 > balance Sheet > equity
-2136108
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-4060787
Quarters > 1 > cash Flow > depreciation
113229
Quarters > 1 > cash Flow > change In Working Capital
25927
Quarters > 1 > cash Flow > cash From Operations
-2647206
Quarters > 1 > cash Flow > capital Expenditures
13427
Quarters > 1 > cash Flow > cash From Investing
-13427
Quarters > 1 > cash Flow > cash From Financing
3018762
Quarters > 1 > cash Flow > net Change In Cash
358129
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-5.07143213965466
Quarters > 1 > ratios > PB
-0.5087825809369189
Quarters > 1 > ratios > ROE
190.10213903042356
Quarters > 1 > ratios > ROA
-85.47090921528286
Quarters > 1 > ratios > FCF
-2660633
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2.0958398025022786
Quarters > 1 > health Score
31
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1853597
Quarters > 2 > income Statement > cost Of Revenue
1367860
Quarters > 2 > income Statement > gross Profit
485737
Quarters > 2 > income Statement > operating Expenses
3112876
Quarters > 2 > income Statement > operating Income
-2627139
Quarters > 2 > income Statement > interest Expense
15485
Quarters > 2 > income Statement > pretax Income
-2651722
Quarters > 2 > income Statement > net Income
-2660417
Quarters > 2 > income Statement > eps
-4.909424248016239
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
541900
Quarters > 2 > income Statement > income Tax Expense
8695
Quarters > 2 > income Statement > EBITDA
-2481649
Quarters > 2 > income Statement > operating Margin
-141.7319406537667
Quarters > 2 > income Statement > total Other Income Expense Net
-24583
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
444706
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
963744
Quarters > 2 > balance Sheet > inventories
38782
Quarters > 2 > balance Sheet > total Current Assets
1863782
Quarters > 2 > balance Sheet > property Plant Equipment
1498784
Quarters > 2 > balance Sheet > total Assets
5547283
Quarters > 2 > balance Sheet > payables
1381578
Quarters > 2 > balance Sheet > short Term Debt
638692
Quarters > 2 > balance Sheet > long Term Debt
48156
Quarters > 2 > balance Sheet > total Liabilities
4107879
Quarters > 2 > balance Sheet > equity
1439404
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-2660417
Quarters > 2 > cash Flow > depreciation
154588
Quarters > 2 > cash Flow > change In Working Capital
537438
Quarters > 2 > cash Flow > cash From Operations
-1641775
Quarters > 2 > cash Flow > capital Expenditures
50786
Quarters > 2 > cash Flow > cash From Investing
-50786
Quarters > 2 > cash Flow > cash From Financing
1031976
Quarters > 2 > cash Flow > net Change In Cash
-660585
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-4.909424248016239
Quarters > 2 > ratios > PB
0.5109898749760317
Quarters > 2 > ratios > ROE
-184.82767867811955
Quarters > 2 > ratios > ROA
-47.95891970898186
Quarters > 2 > ratios > FCF
-1692561
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.9131224316828307
Quarters > 2 > health Score
20
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2207593
Quarters > 3 > income Statement > cost Of Revenue
1715798
Quarters > 3 > income Statement > gross Profit
491795
Quarters > 3 > income Statement > operating Expenses
3438348
Quarters > 3 > income Statement > operating Income
-2946553
Quarters > 3 > income Statement > interest Expense
25045
Quarters > 3 > income Statement > pretax Income
-2966897
Quarters > 3 > income Statement > net Income
-2966897
Quarters > 3 > income Statement > eps
-7.182604759034248
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
413067
Quarters > 3 > income Statement > income Tax Expense
-23300
Quarters > 3 > income Statement > EBITDA
-2788222
Quarters > 3 > income Statement > operating Margin
-133.47356147623225
Quarters > 3 > income Statement > total Other Income Expense Net
-20344
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1105291
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1139204
Quarters > 3 > balance Sheet > inventories
27608
Quarters > 3 > balance Sheet > total Current Assets
2695098
Quarters > 3 > balance Sheet > property Plant Equipment
1619268
Quarters > 3 > balance Sheet > total Assets
6513667
Quarters > 3 > balance Sheet > payables
987311
Quarters > 3 > balance Sheet > short Term Debt
694468
Quarters > 3 > balance Sheet > long Term Debt
20180
Quarters > 3 > balance Sheet > total Liabilities
3911631
Quarters > 3 > balance Sheet > equity
2602036
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2966897
Quarters > 3 > cash Flow > depreciation
153632
Quarters > 3 > cash Flow > change In Working Capital
902017
Quarters > 3 > cash Flow > cash From Operations
-1677161
Quarters > 3 > cash Flow > capital Expenditures
1
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
2025873
Quarters > 3 > cash Flow > net Change In Cash
348711
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-7.182604759034248
Quarters > 3 > ratios > PB
0.21546813306964238
Quarters > 3 > ratios > ROE
-114.02213497430473
Quarters > 3 > ratios > ROA
-45.548797628125605
Quarters > 3 > ratios > FCF
-1677162
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.759724278886552
Quarters > 3 > health Score
24
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
9362000
Annuals > 0 > income Statement > cost Of Revenue
5983000
Annuals > 0 > income Statement > gross Profit
3379000
Annuals > 0 > income Statement > operating Expenses
12332000
Annuals > 0 > income Statement > operating Income
-8953000
Annuals > 0 > income Statement > interest Expense
92475
Annuals > 0 > income Statement > pretax Income
-9028350
Annuals > 0 > income Statement > net Income
-9040000
Annuals > 0 > income Statement > eps
-22.35780903364306
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
404333
Annuals > 0 > income Statement > income Tax Expense
11650
Annuals > 0 > income Statement > EBITDA
-8330000
Annuals > 0 > income Statement > operating Margin
-95.631275368511
Annuals > 0 > income Statement > total Other Income Expense Net
-75350
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1105291
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1139204
Annuals > 0 > balance Sheet > inventories
27608
Annuals > 0 > balance Sheet > total Current Assets
2695098
Annuals > 0 > balance Sheet > property Plant Equipment
1619268
Annuals > 0 > balance Sheet > total Assets
6513667
Annuals > 0 > balance Sheet > payables
987311
Annuals > 0 > balance Sheet > short Term Debt
694468
Annuals > 0 > balance Sheet > long Term Debt
20180
Annuals > 0 > balance Sheet > total Liabilities
3911631
Annuals > 0 > balance Sheet > equity
2602036
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-9039831
Annuals > 0 > cash Flow > depreciation
605637
Annuals > 0 > cash Flow > change In Working Capital
179718
Annuals > 0 > cash Flow > cash From Operations
-7264795
Annuals > 0 > cash Flow > capital Expenditures
79083
Annuals > 0 > cash Flow > cash From Investing
-79083
Annuals > 0 > cash Flow > cash From Financing
5627599
Annuals > 0 > cash Flow > net Change In Cash
-1716279
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-22.35780903364306
Annuals > 0 > ratios > PB
0.21091221677947575
Annuals > 0 > ratios > ROE
-347.4202509112095
Annuals > 0 > ratios > ROA
-138.7851113666081
Annuals > 0 > ratios > FCF
-7343878
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-0.7844347361674856
Annuals > 0 > health Score
23
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2532000
Annuals > 1 > income Statement > cost Of Revenue
1741000
Annuals > 1 > income Statement > gross Profit
791615
Annuals > 1 > income Statement > operating Expenses
8765000
Annuals > 1 > income Statement > operating Income
-7973000
Annuals > 1 > income Statement > interest Expense
37125
Annuals > 1 > income Statement > pretax Income
-7916000
Annuals > 1 > income Statement > net Income
-7937000
Annuals > 1 > income Statement > eps
-27.218792866941016
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
291600
Annuals > 1 > income Statement > income Tax Expense
20993
Annuals > 1 > income Statement > EBITDA
-7629000
Annuals > 1 > income Statement > operating Margin
-314.88941548183254
Annuals > 1 > income Statement > total Other Income Expense Net
57210
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2821570
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
811674
Annuals > 1 > balance Sheet > inventories
18484
Annuals > 1 > balance Sheet > total Current Assets
3972745
Annuals > 1 > balance Sheet > property Plant Equipment
1994789
Annuals > 1 > balance Sheet > total Assets
8221552
Annuals > 1 > balance Sheet > payables
604789
Annuals > 1 > balance Sheet > short Term Debt
460171
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
3366297
Annuals > 1 > balance Sheet > equity
4855255
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-7937011
Annuals > 1 > cash Flow > depreciation
249592
Annuals > 1 > cash Flow > change In Working Capital
900790
Annuals > 1 > cash Flow > cash From Operations
-6037806
Annuals > 1 > cash Flow > capital Expenditures
22902
Annuals > 1 > cash Flow > cash From Investing
-2209399
Annuals > 1 > cash Flow > cash From Financing
-344984
Annuals > 1 > cash Flow > net Change In Cash
-8592189
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-27.218792866941016
Annuals > 1 > ratios > PB
0.08151758867453923
Annuals > 1 > ratios > ROE
-163.47236138987552
Annuals > 1 > ratios > ROA
-96.53895031011176
Annuals > 1 > ratios > FCF
-6060708
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.393644549763033
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4803
Annuals > 2 > income Statement > cost Of Revenue
467
Annuals > 2 > income Statement > gross Profit
4336
Annuals > 2 > income Statement > operating Expenses
4015394
Annuals > 2 > income Statement > operating Income
-4011058
Annuals > 2 > income Statement > interest Expense
2533000
Annuals > 2 > income Statement > pretax Income
-8151654
Annuals > 2 > income Statement > net Income
-8154113
Annuals > 2 > income Statement > eps
-54.372715330706086
Annuals > 2 > income Statement > dividends Per Share
185
Annuals > 2 > income Statement > shares Outstanding
149967
Annuals > 2 > income Statement > income Tax Expense
2459
Annuals > 2 > income Statement > EBITDA
-5608832
Annuals > 2 > income Statement > operating Margin
-83511.51363731002
Annuals > 2 > income Statement > total Other Income Expense Net
-4140596
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
11413759
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
10489
Annuals > 2 > balance Sheet > inventories
5540
Annuals > 2 > balance Sheet > total Current Assets
11961687
Annuals > 2 > balance Sheet > property Plant Equipment
214438
Annuals > 2 > balance Sheet > total Assets
12182125
Annuals > 2 > balance Sheet > payables
345042
Annuals > 2 > balance Sheet > short Term Debt
251746
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1138682
Annuals > 2 > balance Sheet > equity
11043443
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-8154113
Annuals > 2 > cash Flow > depreciation
10182
Annuals > 2 > cash Flow > change In Working Capital
114203
Annuals > 2 > cash Flow > cash From Operations
-4070845
Annuals > 2 > cash Flow > capital Expenditures
219987
Annuals > 2 > cash Flow > cash From Investing
-219987
Annuals > 2 > cash Flow > cash From Financing
14343953
Annuals > 2 > cash Flow > net Change In Cash
10053121
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-54.372715330706086
Annuals > 2 > ratios > PB
0.018431770698685183
Annuals > 2 > ratios > ROE
-73.83669205337502
Annuals > 2 > ratios > ROA
-66.93506264301179
Annuals > 2 > ratios > FCF
-4290832
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-893.3649802206954
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1306
Annuals > 3 > income Statement > cost Of Revenue
4817
Annuals > 3 > income Statement > gross Profit
-4817
Annuals > 3 > income Statement > operating Expenses
2202005
Annuals > 3 > income Statement > operating Income
-2206822
Annuals > 3 > income Statement > interest Expense
1002000
Annuals > 3 > income Statement > pretax Income
-6324463
Annuals > 3 > income Statement > net Income
-6326413
Annuals > 3 > income Statement > eps
-25.724132182342345
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
245933
Annuals > 3 > income Statement > income Tax Expense
1950
Annuals > 3 > income Statement > EBITDA
-5317792
Annuals > 3 > income Statement > operating Margin
-168975.65084226648
Annuals > 3 > income Statement > total Other Income Expense Net
-4117641
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1360638
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1530
Annuals > 3 > balance Sheet > inventories
71846
Annuals > 3 > balance Sheet > total Current Assets
1438233
Annuals > 3 > balance Sheet > property Plant Equipment
4633
Annuals > 3 > balance Sheet > total Assets
1453308
Annuals > 3 > balance Sheet > payables
230407
Annuals > 3 > balance Sheet > short Term Debt
11204225
Annuals > 3 > balance Sheet > long Term Debt
160184
Annuals > 3 > balance Sheet > total Liabilities
17244027
Annuals > 3 > balance Sheet > equity
-15790719
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-6326413
Annuals > 3 > cash Flow > depreciation
4817
Annuals > 3 > cash Flow > change In Working Capital
632821
Annuals > 3 > cash Flow > cash From Operations
-2048978
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
3326508
Annuals > 3 > cash Flow > net Change In Cash
1277530
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-25.724132182342345
Annuals > 3 > ratios > PB
-0.02113930726650256
Annuals > 3 > ratios > ROE
40.06412247599365
Annuals > 3 > ratios > ROA
-435.3112347829916
Annuals > 3 > ratios > FCF
-2048978
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-1568.895865237366
Annuals > 3 > health Score
30
Valuation > metrics > PE
-4.73679748675388
Valuation > metrics > PB
0.162584212910115
Valuation > final Score
70
Valuation > verdict
83.7% Undervalued
Profitability > metrics > ROE
-56.73974000578285
Profitability > metrics > ROA
-58.640759746847024
Profitability > metrics > Net Margin
-3.4929830312032784
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.2970245101266002
Risk > metrics > Interest Coverage
-427.92945128779394
Risk > final Score
-1652
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.441952837124218
Liquidity > metrics > Quick Ratio
6.4156019956458366
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
40
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-932
Prev Risks > 1
-661
Prev Risks > 2
-441
Prev Liquidities > 0
78
Prev Liquidities > 1
55
Prev Liquidities > 2
90
Updated At
2026-01-20T21:29:14.480Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-12
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-4.74
Earnings History > 0 > eps Estimate
-0.0942
Earnings History > 0 > eps Difference
-4.6458
Earnings History > 0 > surprise Percent
-4931.8471
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.17
Earnings History > 1 > eps Estimate
-0.1
Earnings History > 1 > eps Difference
-0.07
Earnings History > 1 > surprise Percent
-70
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-20
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.1905
Earnings History > 2 > eps Estimate
-0.17
Earnings History > 2 > eps Difference
-0.0205
Earnings History > 2 > surprise Percent
-12.0588
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.19
Earnings History > 3 > eps Estimate
-0.14
Earnings History > 3 > eps Difference
-0.05
Earnings History > 3 > surprise Percent
-35.7143
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.16
Earnings History > 4 > eps Estimate
-0.15
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-6.6667
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-14
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.19
Earnings History > 5 > eps Estimate
-0.17
Earnings History > 5 > eps Difference
-0.02
Earnings History > 5 > surprise Percent
-11.7647
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2567
Earnings History > 6 > eps Estimate
-0.2
Earnings History > 6 > eps Difference
-0.0567
Earnings History > 6 > surprise Percent
-28.35
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-05
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0
Earnings History > 7 > eps Estimate
-0.2
Earnings History > 7 > eps Difference
0.2
Earnings History > 7 > surprise Percent
100
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.26
Earnings History > 8 > eps Estimate
-0.15
Earnings History > 8 > eps Difference
-0.11
Earnings History > 8 > surprise Percent
-73.3333
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.2
Earnings History > 9 > eps Estimate
-0.2
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.18
Earnings History > 10 > eps Estimate
-0.18
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.19
Earnings History > 11 > eps Estimate
-0.19
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-1.17
Earnings History > 12 > eps Estimate
-1.17
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-09-02
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.03
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-06-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.48
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ACancer test lab keeps gold-standard accreditation after inspection Stock Titan
Read more →bioAffinity Labs Maintain CAP Accreditation, Supporting CyPath Lung TipRanks
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$6
Analyst Picks
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 2.26% of the total shares of bioAffinity Technologies, Inc.
1.
Geode Capital Management, LLC(0.4243%)
since
2025/06/30
2.
Fidelity Extended Market Index(0.3436%)
since
2025/07/31
3.
Vanguard Institutional Extnd Mkt Idx Tr(0.1976%)
since
2025/07/31
4.
Hanson Mcclain Inc(0.1817%)
since
2025/06/30
5.
Sheaff Brock Investment Advisors, LLC(0.1817%)
since
2025/03/31
6.
Vanguard Group Inc(0.1374%)
since
2025/06/30
7.
CapTrust Financial Advisors(0.0943%)
since
2025/06/30
8.
IFP Advisors, LLC(0.0845%)
since
2025/06/30
9.
Fidelity Series Total Market Index(0.0711%)
since
2025/07/31
10.
Fidelity Nasdaq Composite Index(0.0611%)
since
2025/07/31
11.
State Street Corp(0.0595%)
since
2025/06/30
12.
XTX Topco Ltd(0.0528%)
since
2025/06/30
13.
StoneX Group Inc(0.0514%)
since
2025/06/30
14.
Fidelity Total Market Index(0.0463%)
since
2025/07/31
15.
Northern Trust Corp(0.0462%)
since
2025/06/30
16.
Creative Planning Inc(0.0409%)
since
2025/06/30
17.
Spartan Total Market Index Pool G(0.0374%)
since
2025/07/31
18.
SPROTT INC.(0.0338%)
since
2025/06/30
19.
NT Ext Equity Mkt Idx Fd - NL(0.0318%)
since
2025/06/30
20.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0247%)
since
2025/06/30
21.
NT Ext Equity Mkt Idx Fd - L(0.0144%)
since
2025/06/30
22.
Northern Trust Extended Eq Market Idx(0.0144%)
since
2025/06/30
23.
Tower Research Capital LLC(0.0106%)
since
2025/06/30
24.
Citigroup Inc(0.005%)
since
2025/06/30
25.
NT Ext Eq Mkt Indx Fd DC Lending Tier 5(0.0041%)
since
2025/06/30
26.
NT Ext Eq Mkt Indx Fd DC Lend T3(0.0034%)
since
2024/12/31
27.
Spartan Extended Market Index Pool F(0.0024%)
since
2025/07/31
28.
Bank of America Corp(0.0007%)
since
2025/06/30
29.
Morgan Stanley - Brokerage Accounts(0.0003%)
since
2025/06/30
30.
UBS Group AG(0.0001%)
since
2025/06/30
31.
Warberg Asset Management LLC(0%)
since
2025/06/30
32.
Barclays PLC(0%)
since
2025/06/30
33.
Citadel Advisors Llc(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-4.74
EPS Estimate
-0.0942
EPS Difference
-4.6458
Surprise Percent
-4931.8471%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.